ArticlemedRxiv : the preprint server for health sciences2021

The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD.

Fatima Amanat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.